Ameliorating effect of Kalpaamruthaa, a Siddha preparation in adjuvant induced arthritis in rats with reference to changes in proinflammatory cytokines and acute phase proteins

Chemico-Biological Interactions

Volumn 179, Issue 2-3, 2009, Pages 335-343

  Mythilypriya, Rajendran ^a   Shanthi, Palanivelu ^a   Sachdanandam, Panchanadam ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Acute phase proteins; Emblica officinalis; Proinflammatory cytokines; Rheumatoid arthritis; Semecarpus anacardium nut milk extract

Indexed keywords

ANTIRHEUMATIC AGENT; AYURVEDIC DRUG; C REACTIVE PROTEIN; CERULOPLASMIN; FIBRINOGEN; HERBACEOUS AGENT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; KALPAAMRUTHAA; SEMECARPUS ANACARDIUM EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AYURVEDA; BONE DESTRUCTION; CARTILAGE DEGENERATION; CELL DAMAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ELECTRON MICROSCOPY; EMBLICA OFFICINALIS; EXTRACELLULAR MATRIX; FRUIT; HISTOPATHOLOGY; HONEY; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; JOINT RADIOGRAPHY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; TREATMENT OUTCOME;

ACUTE-PHASE PROTEINS; ANIMALS; ARTHRITIS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; IMMUNOGLOBULINS; INTERLEUKIN-1BETA; MALE; MICROSCOPY, ELECTRON; PLANT EXTRACTS; RATS; RATS, WISTAR; SEMECARPUS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; PHYLLANTHUS EMBLICA; RATTUS; SEMECARPUS ANACARDIUM;

EID: 62549099495     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.01.001     Document Type: Article

References (85)

1. Krane S.M., Conca W., Stephenson M.L., Amento E.P., and Goldring M.B. Mechanisms of matrix degradation in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 580 (1990) 340-354
2. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14 (1996) 397-440
3. Arend W.P., Malyak M., Bigler C.F., Smith Jr. M.F., and Janson R.W. The biological role of naturally-occurring cytokine inhibitors. Br. J. Rheumatol. 30 (1991) 49-52
4. Panayi G.S. Cytokines and anticytokines. Clin. Exp. Rheumatol. 8 (1990) 65-66
5. Moore A.R., Iwamura H., Larbre J.P., Scott D.L., and Willoughby D.A. Cartilage degradation by polymorphonuclear leucocytes: in vitro assessment of the pathogenic mechanisms. Ann. Rheum. Dis. 52 (1993) 27-31
6. Yelin E., and Wanke L.A. An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline. Arthritis Rheum. 42 (1999) 1209-1218
7. Kushner I. The acute phase response: from hippocrates to cytokine biology. Eur. Cytokine Netw. 2 (1991) 75-80
8. Conaghan P.G., Green M.J., and Emery P. Established rheumatoid arthritis. Bailliere Best. Pract. Res. Clin. Rheumatol. 13 (1999) 561-575
9. Connor J.R., Manning P.T., Settle S.L., Moore W.M., Jetome G.M., Webber R.K., Tjoeng F.S., and Currie M.G. Suppression of adjuvant induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol. 273 (1995) 15-24
10. Mythilypriya R., Shanthi P., and Sachdanandam P. Oral acute and subacute toxicity studies with Kalpaamruthaa, a modified indigenous preparation, on rats. J. Health Sci. 53 (2007) 351-358
11. Mythilypriya R., Shanthi P., and Sachdanandam P. Restorative and synergistic efficacy of Kalpaamruthaa, a modified Siddha preparation, on an altered antioxidant status in adjuvant induced arthritic rat model. Chem. Biol. Interact. 168 (2007) 193-202
12. Arulkumaran S., Ramprasath V.R., Shanthi P., and Sachdanandam P. Restorative effect of Kalpaamruthaa, an indigenous preparation, on oxidative damage in mammary gland mitochondrial fraction in experimental mammary carcinoma. Mol. Cell. Biochem. 291 (2006) 77-82
13. Mythilypriya R., Shanthi P., and Sachdanandam P. Analgesic, antipyretic and ulcerogenic properties of an indigenous formulation-Kalpaamruthaa. Phytother. Res. 21 (2007) 574-578
14. Veena K., Shanthi P., and Sachdanandam P. Anticancer effect of Kalpaamruthaa on mammary carcinoma in rats with reference to glycoprotein components, lysosomal and marker enzymes. Biol. Pharm. Bull. 29 (2006) 565-569
15. Veena K., Shanthi P., and Sachdanandam P. The biochemical alterations following administration of Kalpaamruthaa and Semecarpus anacardium in mammary carcinoma. Chem. Biol. Interact. 161 (2006) 69-78
16. Bors W., Michel C., and Schikora S. Interaction of flavonoids with ascorbate and determination of their univalent redox potentials: a pulse radiolysis study. Free Radic. Biol. Med. 19 (1995) 45-52
17. Premalatha B. Semecarpus anacardium Linn. nuts-a boon in alternative medicine. Indian J. Exp. Biol. 38 (2000) 1177-1182
18. Ghosal S., Tripathi V.K., and Chouhan S. Active constituents of Emblica officinalis. Part I. The chemistry and anti-oxidant effect of two new hydrolysable tannins, Emblicanin A & B. Indian J. Chem. B 35 (1996) 941-948
19. Formulary of Siddha Medicine, Published by the Indian Medical Practitioners Co-operative Pharmacy and Stores Ltd., Madras, India, 1972.
20. Vijayalakshmi T., Muthulakshmi V., and Sachdanandam P. Effect of the milk extract of Semecarpus anacardium nut on adjuvant arthritis-a dose-dependent study in Wistar albino rats. Gen. Pharmacol. 27 (1996) 1223-1226
21. Mythilypriya R., Shanthi P., and Sachdanandam P. Therapeutic effect of Kalpaamruthaa a herbal preparation on adjuvant induced arthritis in Wistar rats. Inflammopharmacology 16 (2007) 21-35
22. Connell E.D., and Connell J.T. C-reactive protein in pregnancy and contraception. Am. J. Obstet. Gynecol. 110 (1971) 633-639
23. Ravin J.A. Improved colorimetric enzymatic assay of ceruloplasmin. J. Lab. Clin. Med. 58 (1961) 161-168
24. Lempert H. Determination of plasma protein. In: Varley H. (Ed). Practical Clinical Biochemistry (1969), CBS Publishers, New Delhi 233
25. Tennant B., Baldwin B.H., Braun R.K., Norcross N.L., and Sandholm M. Use of the glutaraldehyde coagulation test for the detection of hypogamma-globulinemia in neonatal calves. Am. J. Vet. Med. 174 (1979) 848-853
26. Satpathy P.K., Dutta N.K., Mishra P.R., and Kar B.C. Glutaraldehyde coagulation test standard curve and its applications to detect gammaglobulin level in kids. Ind. Vet. J. 73 (1996) 257-260
27. Smith-Oliver T., Noel L.S., Stimpson S.S., Yarnall D.P., and Connolly K.M. Elevated levels of TNF in the joints of adjuvant arthritic rats. Cytokine 5 (1993) 298-304
28. Sharma M., and Singh O. Immunoassays. Murine and Human Monoclonal Antibodies, Practical Manual (1989), National Institute of Immunology, New Delhi pp. 27-29
29. Lowry O.H., Rosenbrough N.J., Farn A.L., and Randall R.J. Protein measurement with Folin's phenol reagent. J. Biol. Chem. 193 (1951) 176-265
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
31. van de Loo A.A., Arntz O.J., Bakker A.C., van Lent P.L., Jacobs M.J., and van den Berg W.B. Role of interleukin 1 in antigen-induced exacerbations of murine arthritis. Am. J. Pathol. 146 (1995) 239-249
32. Wooley P.H., Whalen J.D., Chapman D.L., Berger A.E., Richard K.A., Aspar D.G., and Staite. The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum. 36 (1993) 1305-1314
33. Ohshima S., Saeki Y., Mima T., Sasai M., Nishioka K., Nomura S., Kopf M., Katada Y., Tanaka T., Suemura M., and Kishimoto T. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc. Natl. Acad. Sci. 95 (1998) 8222-8226
34. Joosten L.A., Helsen M.M., van de Loo F.A., and van den Berg W.B. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra. Arthritis Rheum. 39 (1996) 797-809
35. Moreland L.W. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 349 (2003) 1907-1915
36. Wang Y., Fang Y., Huang W., Zhou X., Wang M., Zhong B., and Peng D. Effect of sinomenine on cytokine expression of macrophages and synoviocytes in adjuvant arthritis rats. J. Ethnopharmacol. 98 (2005) 37-43
37. Zangerle P.F., De Groote D., Lopez M., Meuleman R.J., Vrindts Y., Fauchet F., Dehart I., Jadoul M., Radoux D., and Franchimont P. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4 (1992) 568-575
38. Dayer J.M., and Arend W.P. Cytokines and growth factors. In: Kelley W.N., Harris E.D., Ruddy S., and Sledge C.B. (Eds). Textbook of Rheumatology (1997), WB Saunders, Philadelphia 267-286
39. Zhu P., Ding J., Zhou J., Dong W.J., Fan C.M., and Chen Z.N. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production. Arthritis Res. Ther. 7 (2005) R1023-R1033
40. van den Berg W.B., Joosten L.A., Kollias G., and van De Loo F.A. Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction. Ann. Rheum. Dis. 58 (1999) I40-I48
41. Mythilypriya R., Shanthi P., and Sachdanandam P. Efficacy of Siddha formulation Kalpaamruthaa in ameliorating joint destruction in rheumatoid arthritis in rats. Chem. Biol. Interact. 176 (2008) 243-251
42. Kollias G., Douni E., Kassiotis G., and Kontoyiannis D. The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Ann. Rheum. Dis. 58 (1999) I32-I39
43. Dayer J.M. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology 42 (2003) ii3-ii10
44. Liz-Grana M., and Gomez-Reino Carnota J.J. Tumour necrosis factor. Genetics, cell action mechanism and involvement in inflammation. Allergol. Immunol. Clin. 16 (2001) 140-149
45. Bendele A.M., Chlipala E.S., Scherrer J., Frazier J., Sennello G., Rich W.J., and Edwards III C.K. Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis. Arthritis Rheum. 43 (2000) 2648-2659
46. Shingu M., Nagai Y., Isayama T., Naono T., Nobunaga M., and Nagai Y. The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clin. Exp. Immunol. 94 (1993) 145-149
47. Abramson S.B., and Amin A. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology 41 (2002) 972-980
48. Pelletier J.P., Mineau F., Ranger P., Tardif G., and Martel-Pelletier J. The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 4 (1996) 77-84
49. Amin A.R., Dave M., Attur M., and Abramson S.B. COX-2, NO, and cartilage damage and repair. Curr. Rheumatol. Rep. 2 (2000) 447-453
50. Girasole G., Passeri G., Jilka R.L., and Manolagas S.C. Interleukin-11: a new cytokine critical for osteoclast development. J. Clin. Invest. 93 (1994) 1516-1524
51. Burger D., and Dayer J.M. Inhibitory cytokines and cytokine inhibitors. Neurology 45 (1995) S39-S43
52. Ramprasath V.R., Shanthi P., and Sachdanandam P. Curative effect of Semecarpus anacardium Linn. nut milk extract against adjuvant arthritis-with special reference to bone metabolism. Chem. Biol. Interact. 160 (2006) 183-192
53. Jobin C., Bradham C.A., Russo M.P., Juma B., Narula A.S., Brenner D.A., and Sartor R.B. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J. Immunol. 163 (1999) 3474-3483
54. Xagorari A., Papapetropoulos A., Mauromatis A., Economou M., Fotsis T., and Roussos C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J. Pharmacol. Exp. Ther. 296 (2001) 181-187
55. Lin N., Sato T., Takayama Y., Mimaki Y., Sashida Y., Yano M., and Ito A. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem. Pharmacol. 65 (2003) 2065-2071
56. Erdelyi K., Kiss A., Bakondi E., Bai P., Szabo C., Gergely P., Erdodi F., and Virag L. Gallotannin inhibits the expression of chemokines and inflammatory cytokines in A549 cells. Mol. Pharmacol. 68 (2005) 895-904
57. Feldman K.S., Sahasrabudhe K., Lawlor M.D., Wilson S.L., Lang C.H., and Scheuchenzuber W.J. In vitro and in vivo inhibition of LPS-stimulated tumor necrosis factor-alpha secretion by the gallotannin beta-D-pentagalloylglucose. Bioorg. Med. Chem. Lett. 11 (2001) 1813-1815
58. Hartel C., Strunk T., Bucsky P., and Schultz C. Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes. Cytokine 27 (2004) 101-106
59. Glenn E.M., Bowman B.J., and Koslowske T.C. The systemic response to inflammation. Biochem. Pharmacol. Suppl. (1968) 27-49
60. Gough A.K., Lilley J., Eyre S., Holder R.L., and Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344 (1994) 23-27
61. Scott D.L. Prognostic factors in early rheumatoid arthritis. Rheumatology 39 (2000) 24-29
62. Stecher V.J., and Connolly K.M. The relationship between interleukin-1 activity in adjuvant rats and changes in plasma fibronectin, C-reactive protein and albumin levels. Fed. Proc. 46 (1987) 790
63. Wong P.K., Campbell I.K., Egan P.J., Ernst M., and Wicks I.P. The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover. Arthritis Rheum. 48 (2003) 1177-1189
64. Mortensen R.F. Macrophages and acute-phase proteins. Immunol. Ser. 60 (1994) 143-158
65. Tebo J.M., and Mortensen R.F. Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937. J. Immunol. 144 (1990) 231-238
66. Galve-de Rochemonteix B., Wiktorowicz K., Kushner I., and Dayer J.M. C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages. J. Leukoc. Biol. 53 (1993) 439-445
67. Louro M.O., Cocho J.A., Mera A., and Tutor J.C. Immunochemical and enzymatic study of ceruloplasmin in rheumatoid arthritis. J. Trace Elem. Med. Biol. 14 (2000) 174-178
68. Dixon J.S., Greenwood M., and Lowe J.R. Caeruloplasmin concentration and activity in polyarthritis. Rheumatol. Int. 8 (1988) 11-14
69. Peretz A., Neve J., Famaey J.P., and Molle L. Oligo-elements essentials et affectations rhumatismales. J. Pharm. Belg. 42 (1987) 395-403
70. Sox Jr. H.C., and Liang M.H. The erythrocyte sedimentation rate. Guidelines for rational use. Ann. Intern. Med. 104 (1986) 515-523
71. Larsson A., Bjork J., and Lundberg C. Nephelometric determination of rat fibrinogen as a marker of inflammatory response. Vet. Immunol. Immunopathol. 59 (1997) 163-169
72. Badolato R., and Oppenheim J. Role of cytokines, acute-phase proteins, and chemokinesin the progression of rheumatoid arthritis. Semin. Arthritis Rheum. 26 (1996) 526-538
73. Glenn E.M. Fibrinogen and experimental inflammation. Biochem. Pharmacol. 26 (1969) 317-326
74. Madhok R., Crilly A., Watson J., and Capell H.A. Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann. Rheum. Dis. 52 (1993) 232-234
75. Mythilypriya R., Shanthi P., and Sachdanandam P. Synergistic effect of Kalpaamruthaa on antiarthritic and antiinflammatory properties-its mechanism of action. Inflammation 31 (2008) 391-398
76. Feng Y.H., Zou J.P., and Li X.Y. Effects of resveratrol and ethanol on production of pro-inflammatory factors from endotoxin activated murine macrophages. Acta Pharmacol. Sin. 23 (2002) 1002-1006
77. Swedler W., Wallman J., Froelich C.J., and Teodorescu M. Routine measurement of IgM, IgG and IgA rheumatoid factors: high sensitivity, specificity and predictive value of rheumatoid arthritis. J. Rheumatol. 24 (1977) 1037-1044
78. Marcolongo J.R., Carcassi A., Frullini F., Bianco G., and Bravi A. Levels of serum immunoglobulins in patients with rheumatoid arthritis. Ann. Rheum. Dis. 26 (1967) 412-417
79. Claman H.N., and Merill D. Serum immunoglobulins in rheumatoid arthritis. J. Lab. Clin. Med. 67 (1966) 850-854
80. Teitsson I., Withrington R.H., Seifert M.H., and Valdimarsson H. Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor. Ann. Rheum. Dis. 43 (1984) 673-678
81. Westedt M.L., Daha M.R., Baldwin W.M., Stijnen T., and Cats A. Serum immune complexes containing IgA appear to predict erosive arthritis in a longitudinal study in rheumatoid arthritis. Ann. Rheum. Dis. 45 (1986) 809-815
82. Jonsson T., and Vladimarsson H. Clinical significance of rheumatoid factor isotypes in seropositive arthritis. Rheumatol. Int. 12 (1992) 111-113
83. Holmdahl R., Mo J., Nordling C., Larsson P., Jansson L., Goldschmidt T., Andersson M., and Klareskog L. Collagen induced arthritis: an experimental model for rheumatoid arthritis with involvement of both DTH and immune complex mediated mechanisms. Clin. Exp. Rheumatol. 7 (1989) 51-55
84. Carson D.A., Chen P.P., Fox R.I., Kipps T.J., Jirik F., Goldfien R.D., Silverman G., Radoux V., and Fong S. Rheumatoid factor and immune networks. Annu. Rev. Immunol. 5 (1987) 109-126
85. Damre A.S., Gokhale A.B., Phadke A.S., Kulkarni K.R., and Sarat M.N. Studies on the immunomodulatory activity of flavonoidal fraction of Tephrosia purpurea. Fitoterapia 74 (2003) 257-561